{
    "title": "Novo Nordisk bets on new obesity drug recipes",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4495920/Novo-Nordisk-bets-new-obesity-drug-recipes.html",
    "date": "2017-05-11",
    "keywords": [
        "obesity",
        "jorgensen",
        "drug",
        "percent",
        "market",
        "novo",
        "growth",
        "antiobesity",
        "saxenda",
        "business",
        "drugmaker",
        "portfolio",
        "earlystage",
        "price",
        "quarter",
        "product",
        "blood",
        "company",
        "hirschler",
        "london",
        "pressure",
        "insulin",
        "nordisk",
        "cause",
        "executive",
        "graveyard",
        "industry",
        "past",
        "wave",
        "promise",
        "development",
        "belviq",
        "qsymia",
        "weight",
        "loss",
        "reluctance",
        "contrast",
        "injection",
        "glp1",
        "ingredient",
        "victoza",
        "month",
        "consensus",
        "thomson",
        "step",
        "opportunity",
        "dont",
        "lot",
        "space",
        "visit",
        "something",
        "medication",
        "hope",
        "semaglutide",
        "variety",
        "body",
        "phase",
        "goal",
        "boss",
        "time",
        "worlds",
        "maker",
        "demand",
        "squeeze",
        "reputation",
        "erosion",
        "agenda",
        "haemophilia",
        "roche",
        "gene",
        "therapy",
        "mainstay",
        "acquisition",
        "year",
        "matter",
        "offer",
        "valuation",
        "gap",
        "week",
        "target",
        "reporting",
        "carl",
        "odonnell",
        "york",
        "editing",
        "hardcastle"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}